October 2019 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for October 2019. This roundup includes the latest...
Recommendations Developed to Address Clinician Burnout
Six goals include creation of positive work and learning environments that prevent, reduce burnout
Cognitive Ability in Childhood Linked to Cognitive Scores at 70
Childhood cognitive ability, education, socioeconomic position independently linked to cognition
CDC: U.S. Life Expectancy Up Slightly, Mortality Lower in 2017
Report shows decrease in age-adjusted death rates, increase in age-adjusted death rate from overdose
Fetal Exposure to Acetaminophen May Increase Risk for ADHD, ASD
Cord biomarkers of in utero acetaminophen exposure tied to increased risk for childhood ADHD, ASD
Prevalence of Pain Higher in Children With Autism
Association more pronounced among children with autism plus developmental comorbidities
Patients Should Restart Blood Thinners After GI Bleed
Lower risk for ischemic events and death outweigh risk for another bleeding event
CV Risk Score Tied to Subclinical Cerebrovascular Disease on MRI
Association seen between risk scores and MRI-detected subclinical cerebrovascular disease
Aspirin May Slow Growth of Multiple Intracranial Aneurysms
Aspirin linked to decreased rate of aneurysm growth in patients with multiple intracranial aneurysms
Evidence for Use of Cannabinoids to Treat Mental Disorders Lacking
Evidence inadequate for cannabinoid use to relieve depression, anxiety, ADHD, Tourette, PTSD, psychosis
